Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01060306

Optical Coherence Tomography Evaluation of a Biodegradable Polymer-based Drug-eluting Stent

Prospective Optical cohereNce Tomography Evaluation of neoINtimal Coverage of a biodegrAdable Polymer-based Drug-eluting Stent

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Ospedale Santa Maria Goretti · Academic / Other
Sex
All
Age
50 Years – 85 Years
Healthy volunteers
Not accepted

Summary

PONTINA aims at assessing by optical coherence tomography the neointimal coverage of the biodegradable polymer-based Biolimus A9-eluting stent (Biomatrix stent) after full drug elution and polymer biodegradation (6 months), at one month after this time-point (7 months) and, as a comparator, of its bare metal stent counterpart (Gazelle stent) at 1 month after implantation.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2010-08-01
Completion
2011-01-01
First posted
2010-02-02
Last updated
2020-02-24

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01060306. Inclusion in this directory is not an endorsement.

Optical Coherence Tomography Evaluation of a Biodegradable Polymer-based Drug-eluting Stent (NCT01060306) · Clinical Trials Directory